S3 Clinical Research Centers
- Address
- Johanneslundsvägen 3, 194 61 Upplands Vasby, Sweden
S3 Clinical Research Centers
S3 Clinical Research Centers specializes in vaccine research and infectious disease prevention, with a particular focus on conditions affecting older adult populations. The center conducts comprehensive clinical trials evaluating both immediate and long-term outcomes of preventive therapeutics.
- Herpes Zoster (shingles) vaccine efficacy and safety studies
- Long-term immune response monitoring in elderly populations
- Preventive vaccine research for age-related infectious diseases
The center's research program emphasizes vaccine persistence and sustained immunogenicity in older adults, contributing valuable data on the durability of protective immune responses. Through rigorous evaluation of vaccine efficacy and safety profiles over extended follow-up periods, S3 Clinical Research Centers advances our understanding of preventive strategies for infections that disproportionately affect aging populations.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in S3 Clinical Research Centers
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Long-term Evaluation of Efficacy, Safety, and Immune Response Persistence of Recombinant Varicella Zoster Virus Glycoprotein E Vaccine in Herpes Zoster Prevention in Older Adults | GlaxoSmithKline Biologicals | Phase III | Not Recruiting | Aug 2022 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Recombinant Varicella Zoster Virus Glycoprotein E | 1 | Unknown | 2022-08-08 | 2022-08-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.